GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Clariane SE (CHIX:CLARIp) » Definitions » EBIT

Clariane SE (CHIX:CLARIP) EBIT : €189 Mil (TTM As of Jun. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Clariane SE EBIT?

Clariane SE's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was €136 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was €189 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Clariane SE's annualized ROC % for the quarter that ended in Jun. 2024 was 1.51%. Clariane SE's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 3.98%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Clariane SE's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 2.22%.


Clariane SE EBIT Historical Data

The historical data trend for Clariane SE's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clariane SE EBIT Chart

Clariane SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 339.58 255.01 323.62 253.84 201.73

Clariane SE Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 123.61 130.23 148.56 53.17 135.95

Competitive Comparison of Clariane SE's EBIT

For the Medical Care Facilities subindustry, Clariane SE's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clariane SE's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Clariane SE's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Clariane SE's EV-to-EBIT falls into.



Clariane SE EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €189 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clariane SE  (CHIX:CLARIp) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Clariane SE's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=295.702 * ( 1 - 25.83% )/( (14474.698 + 14619.744)/ 2 )
=219.3221734/14547.221
=1.51 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=15180.911 - 1593.566 - ( 677.915 - max(0, 3385.85 - 2498.497+677.915))
=14474.698

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=14614.526 - 1284.038 - ( 516.495 - max(0, 3151.119 - 1861.863+516.495))
=14619.744

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Clariane SE's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=271.896/( ( (6796.709 + max(-501.535, 0)) + (6872.656 + max(-605.403, 0)) )/ 2 )
=271.896/( ( 6796.709 + 6872.656 )/ 2 )
=271.896/6834.6825
=3.98 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(565.166 + 28.297 + 840.495) - (1593.566 + 0 + 341.927)
=-501.535

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(618.907 + 25.493 + 373.44) - (1284.038 + 0 + 339.205)
=-605.403

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Clariane SE's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2024 )
=189.118/8537.665
=2.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clariane SE EBIT Related Terms

Thank you for viewing the detailed overview of Clariane SE's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Clariane SE Business Description

Traded in Other Exchanges
Address
21-25, Rue Balzac, Paris, FRA, 75008
Clariane SE operates nursing homes, post-acute and rehabilitation clinics, assisted living facilities, and home care services. Its operating segments are France, Germany, Italy, and Belgium. The majority of its revenue is generated in France. Its nursing homes offer long-term care and medical support for elderly people.

Clariane SE Headlines

No Headlines